Data protection Impressum

Healthcare

Neurotechnology company ONWARD Medical extends its cash runway through 2026 and prepares to expand commercialization and clinical development of its ARC Therapy systems.

ONWARD Medical raises over EUR 50 million to advance spinal cord therapies

27 October 2025

Adaptyv raises USD 8 million to accelerate AI-powered protein validation

27 October 2025

Vaud-based FemTech company Aspivix begins commercial rollout in Southern California and New York following strong clinical validation and growing U.S. demand.

Aspivix launches its breakthrough Carevix device in the United States

21 October 2025

Lausanne-based biotech ADC Therapeutics has secured USD 60 million in new financing to expand commercialization of its cancer treatment ZYNLONTA.

ADC Therapeutics raises USD 60 million to strengthen oncology portfolio

21 October 2025

EssilorLuxottica’s acquisition of RetinAI strengthens its medtech portfolio with advanced AI and data-driven solutions for eye disease management.

EssilorLuxottica acquires Bern-based RetinAI to accelerate AI-powered eye health innovation

20 October 2025

A CHF 2.1 million endowed professorship will strengthen data-driven cancer medicine at the University of Bern and Inselspital.

New endowed professorship to advance digital cancer medicine in Bern

13 October 2025

Geneva-based medtech company Spineart has secured a CHF 25 million investment from long-standing shareholders Gimv and EGS Beteiligungen (EGSB) to fuel its next phase of growth and global expansion.

Spineart raises CHF 25 million to accelerate global expansion and innovation

6 October 2025

Geneva-based Multiwave Technologies has secured CHF 3.6 million to accelerate regulatory approval of its portable MRI device and establish a new assembly facility in the United States.

Multiwave raises CHF 3.6 million and opens US operations in Boston

1 October 2025

French robotics company Meanwhile has chosen Fribourg for its first international subsidiary, strengthening its presence in Switzerland and reinforcing its capacity to serve clients across the country.

Meanwhile opens its first international subsidiary in Fribourg

22 September 2025

Geneva-based EarlySight has raised an additional CHF 3.1 million, bringing its seed financing round to CHF 6.1 million, to launch its next-generation product and advance U.S. approval.

Retinal imaging specialist EarlySight raises CHF 3.1 million to accelerate global growth

10 September 2025

1 2 3 4 5 … 21